A5021543615- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Cardiac pacing and defibrillation studies
- Peripheral Artery Disease Management
- Heart Failure Treatment and Management
- Congenital Heart Disease Studies
- Cardiac and Coronary Surgery Techniques
- Acute Myocardial Infarction Research
- Vascular Procedures and Complications
- Venous Thromboembolism Diagnosis and Management
- Cardiac Arrest and Resuscitation
- Cardiac electrophysiology and arrhythmias
- Cardiac Valve Diseases and Treatments
- Pain Management and Treatment
- Cardiac Arrhythmias and Treatments
- Sarcoma Diagnosis and Treatment
- Healthcare Policy and Management
- ECG Monitoring and Analysis
- Renal Transplantation Outcomes and Treatments
- Sepsis Diagnosis and Treatment
- Transplantation: Methods and Outcomes
- Atrial Fibrillation Management and Outcomes
- Hemodynamic Monitoring and Therapy
- Energy Efficient Wireless Sensor Networks
- Nutritional Studies and Diet
Latakia University
2025
University of Michigan
2012-2019
Wayne State University
2009-2018
Michigan United
2018
Michigan Medicine
2018
Detroit Medical Center
2018
University of Jordan
2012
Providence Hospital
2009-2011
ABSTRACT Background The most frequent type of non‐Hodgkin lymphoma (NHL) is diffuse large B‐cell (DLBCL). Although lymph nodes are the commonly affected organs compromising 70% DLBCLs, only 5% extranodal lymphomas represent skeletal muscle involvement. Specifically, abdominal wall involvement rare and there a few reported cases DLBCL with this Painful mass was main presenting symptom in these cases. Case We reporting relapsed 65‐year‐old male, discomfort heaviness sensation right iliac...
Background Right ventricular (RV) failure due to pulmonary embolism (PE) increases morbidity and mortality contributes prolonged hospital length of stay higher costs care. RV mechanical circulatory support (MCS) including Impella RP devices have been increasingly used in hemodynamically compromised PE patients who are refractory intravascular volume expansion inotropic therapy. However, effectiveness safety RP, unstable is unknown. Methods We included consecutive presented Detroit Medical...
Systemic inflammation during implant of a durable left ventricular assist device (LVAD) may contribute to adverse outcomes. We investigated the association preoperative inflammatory markers with subsequent right failure (RVF). Prospective data was collected on 489 patients from 2003 through 2017 who underwent implantation LVAD. Uni- and multivariable correlation leukocytosis determined using linear binary logistic regression. The population also separated into low (< 10.5 K/ul, n = 362) high...
Inotropes are associated with adverse outcomes in heart failure (HF), raising concern they may accelerate myocardial injury. Whether biomarkers of necrosis, inflammation and apoptosis change response to acute milrinone administration is not well established. Ten patients severe HF reduced cardiac output who were receive studied. Blood samples taken just before initiation after 24 hours infusion. Dosing was at the discretion patient's attending physician (range 0.25–0.5 mcg/kg/min). Plasma...
Introduction: Patients in underdeveloped nations have limited access to life‐saving medical technology including cardiac rhythm management (CRM) devices. We evaluated alternative means provide such this patient population while assessing the safety and efficacy of a practice. Methods: United States with clinical indications for extraction CRM devices were consented. Antemortem cleaned sterilized following protocol established at our institution. Surveillance vitro cultures performed quality...
Abstract Objective To assess the in‐hospital and short‐term outcome differences between males females who underwent high‐risk PCI with mechanical circulatory support (MCS). Background Sex have been noted in several percutaneous coronary intervention (PCI) series less likely to be referred for due increased risk of adverse events. However, data on sex utilization outcomes MCS is scarce. Methods Using cVAD Registry, we identified 1,053 patients using Impella 2.5 or CP. Patients cardiogenic...
Purpose of review As the number people living with heart failure continues to grow, future treatments will focus on efficient donor organ donation and ensuring safe durable outcomes. This procurement, graft surveillance emerging therapies. Recent findings Preliminary studies into after cardiac death have indicated that this may be an effective means increase pool. Novel preservation techniques include ex-vivo perfusion improve metabolic stabilization prior implantation also expand...
Background: The Impella 2.5 and Cardiac Power (CP) devices (ABIOMED) are used to provide mechanical circulatory support for high-risk percutaneous coronary interventions or cardiogenic shock as a bridge recovery destination therapy. device has shown both efficacy safety in patients presenting with shock. Performing clinical hemodynamic assessments of is an important step determine if indicated. Case Report: A 62-year-old male presented requiring support. Two days later, the patient developed...
Wireless sensor networks (WSN) have become very popular in the last few years. One key issue about WSN is that nodes a limited battery capacity. For that, it important to develop energy efficient solutions keep these functioning for longest period of time. Since most spent on data transmission, many routing techniques been proposed expand network lifetime such as Online Maximum Lifetime heuristics (OML) and capacity maximization (CMAX). The OML has obtained best literature. In this paper, we...
Background: The predictors of left ventricular thrombus (LVT) formation and resolution, post-acute myocardial infarction (MI), (LV) dysfunction significantly impact management strategies need updating to reflect contemporary practice. Methods: Transthoracic echocardiography was used screen assess MI patients with LV ejection fraction (LVEF) <35% or <40% apical akinesis dyskinesis. Results: We enrolled 979 patients. Of them, 67 (6.84%) had an LVT at the baseline. Additionally, 22 7...